How do you document critical thinking under FDA's CSA guidance?
Capture five elements for each assurance activity: the risk-based rationale, a testing summary, any issues found, a conclusion, and a named approval with a date — as laid out in FDA's final September 2025 guidance. The rationale is what proves a lighter testing approach was a deliberate risk-based decision, not corners cut to save time.
Two teams run the exact same scenario-based test on the exact same low-risk feature. One writes "Pass." The other writes why that level of testing was enough. Only one of them can defend the decision six months later.
What FDA Actually Expects in the Record
FDA's final CSA guidance, published September 24, 2025, is specific about what an assurance record needs to contain: a risk-based rationale, a testing summary, any issues found, a conclusion, and a named approval with a date. That structure doesn't change based on risk level — what changes is the depth within each element. A low-risk feature might satisfy all five in a few sentences; a GxP-critical function needs the same five elements documented in real depth. The rationale is the one most often left out, because it's the one that takes actual thought rather than a status update.
The Difference a Documented Rationale Makes
Here's the same low-risk feature — a report export button with no GxP data or decision behind it — documented two different ways.
Feature: PDF export button. Testing: scenario-based. Result: Pass.
Feature: PDF export button on the internal review dashboard.
Intended use: Internal review only; no GxP decision or record depends on this output.
Risk rationale: No product quality, patient safety, or data integrity impact if this fails — a failed export is immediately visible to the user and does not feed any downstream decision.
Assurance activity: Scenario-based testing, three representative export scenarios.
Result: Correct output in 3/3 scenarios. No issues found.
Conclusion: Adequate assurance for intended use given no GxP impact. Approved: J. Reyes, QA, 2026-08-04.
Both records describe the same testing. Only the second one survives the question every inspector eventually asks: why was this enough?
Where to Put the Rationale
Keep it as close to the test activity as possible. The practice that holds up best is listing the risk statement directly next to the corresponding test module in the assurance plan, rather than filing it in a separate risk assessment document a reviewer has to go find. If someone has to leave the test record to understand why the testing was scoped the way it was, the documentation isn't doing its job yet.
Common Documentation Mistakes
- Risk tier assigned with no reasoning behind it. "Low risk" is a conclusion, not a rationale — the record needs to show what made it low risk.
- Rationale copy-pasted across systems. Similar systems can share similar reasoning, but a paragraph duplicated verbatim reads as boilerplate, not judgment applied to this specific feature.
- No named reviewer or date. A conclusion without an accountable person and timestamp isn't a record — it's an unattributed opinion.
- Documenting the activity but not the "why enough." Recording what was tested without recording why that was sufficient leaves the exact gap an inspector is trained to probe.
How GoVal Supports Critical Thinking Documentation
GoVal captures the risk-based rationale as a structured field tied directly to each test activity, alongside the testing summary, issues, conclusion, and approval, so the reasoning behind every assurance decision lives exactly where the decision itself is recorded. Risk classification at the system level pre-populates the expected depth for each element, keeping rationale consistent across a portfolio without collapsing into copy-pasted boilerplate.
Related Topics
Frequently Asked Questions
How do you document critical thinking under FDA's CSA guidance? +
What five elements does FDA expect in a CSA assurance record? +
What's the difference between documenting critical thinking and just writing a test report? +
Can the same risk rationale be reused across similar systems? +
Where should the risk rationale be documented — in the risk assessment or the test plan? +
What happens if critical thinking isn't documented, even if the testing itself was appropriate? +
How does GoVal support critical thinking documentation? +
Make every assurance decision defensible, not just correct
Risk-based rationale, testing summary, and approval — captured as one structured record, in GoVal.
